Varicella-zoster virus live attenuated

Classification

1. Anatomical main groupJAnti-infectives for systemic use
2. Therapeutic subgroupJ07
3. Pharmacological subgroupJ07B
4. Chemical subgroupJ07BKVaricella zoster vaccines
5. Chemical substanceJ07BK01Varicella, live attenuated

Where it is registered

Each register with its number of medicines and a few of them.

• 🇨🇦Canada

  Health Canada · 2 medicines

  • Varilrix1995.26231 PFU / 0.5 ML · Powder For Solution · Glaxosmithkline INC
  • Priorix-Tetra1000 CCID50 / 0.5 ML + 25118.9 CCID50 / 0.5 ML + 1000 CCID50 / 0.5 ML + 1995.2623 PFU / 0.5 ML · Powder For Solution · Glaxosmithkline INC

• 🇸🇦Saudi Arabia

  SFDA · 1 medicine · Historical list

  • Priorix-Tetra VaccineGlaxosmithkline (GSK)

All medicines with Varicella-zoster virus live attenuated

Every register, a page at a time. Strengths and packs are on each medicine’s page.